Results 11 to 20 of about 4,744 (174)

Fampridine for Symptomatic Treatment in Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double-Blinded, Placebo-Controlled Crossover Study. [PDF]

J Peripher Nerv Syst
ABSTRACT Background and Aims Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an immune‐mediated neuropathy that may cause persistent disability despite immunoglobulin treatment. Ion channel dysfunction has been demonstrated in CIDP, but no therapies specifically target this mechanism.
Hansen PN, Markvardsen L, Tankisi H, Andersen H, Krøigård T, Sindrup S.   +5 more
europepmc   +2 more sources

Switching From Intravenous to Subcutaneous Immunoglobulin Maintenance Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. [PDF]

J Peripher Nerv Syst
ABSTRACT Background and Aims Subcutaneous immunoglobulin (SCIg) is an alternative maintenance therapy to intravenous immunoglobulin (IVIg) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The CIDP guideline considers switching from IVIg to SCIg at an equivalent dosage reasonable; however, the optimal dosing strategy is unknown. This
Su Y, van Doorn PA, Jacobs BC, Kuitwaard K.   +3 more
europepmc   +2 more sources

Long-Term Safety and Efficacy of Efgartigimod PH20 in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: ADHERE/ADHERE+ Trial Interim Analysis. [PDF]

J Peripher Nerv Syst
ABSTRACT Background and Aims In ADHERE, subcutaneous efgartigimod PH20 (1000 mg once weekly) was effective and well tolerated in participants with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). ADHERE+ is an open‐label extension of ADHERE assessing long‐term safety and efficacy. Methods Eligible participants from ADHERE run‐in period
Allen JA, Istas G, Kuwabara S, Mole T, Querol L, Rinaldi S, Stettner M, Van Hoorick B, Lewis RA.   +8 more
europepmc   +2 more sources

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis. [PDF]

Muscle Nerve
ABSTRACT Introduction/Aims Combined central and peripheral demyelination (CCPD) is a rare dysimmune disorder sharing features with multiple sclerosis (MS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Direct comparisons of central and peripheral diagnostic findings across these entities remain limited. We, therefore, performed a
Dubuisson N, Kassab A, Van den Bergh PYK, Vrancken AFJE, van der Pol WL, van den Berg LH, Goedee HS.   +6 more
europepmc   +2 more sources

Treatment of CIDP

Practical Neurology, 2022
Chronic inflammatory demyelinating polyneuropathy is a disabling but treatable disorder. However, misdiagnosis is common, and it can be difficult to optimise its treatment. Various agents are used both for first and second line. First-line options are intravenous immunoglobulin, corticosteroids and plasma exchange.
Fehmi, J, Bellanti, R, Misbah, SA, Bhattacharjee, A, Rinaldi, S   +4 more
openaire   +3 more sources

CIDP mimics: a case series [PDF]

BMC Neurology, 2021
Abstract Background To report our experience with a group of patients referred for refractory CIDP who fulfilled “definite” electrodiagnostic EFNS criteria for CIDP but were found to have an alternate diagnosis. Methods Patients who were seen between 2017 and 2019 for ...
Orly Moshe-Lilie, Erik Ensrud, Thomas Ragole, Chahin Nizar, Diana Dimitrova, Chafic Karam   +5 more
openaire   +3 more sources

Absence of proximal muscle weakness, dysarthria, and facial diplegia suggests Guillain–Barre syndrome rather than CIDP

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022
The aim of this letter to the editor is to discuss the etiology and pathophysiology of chronic inflammatory demyelinating polyneuropathy (CIDP) in two patients, of whom one experienced a mildly symptomatic SARS-CoV-2 infection 2 months prior to onset of ...
Josef Finsterer
doaj   +1 more source

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes [PDF]

Scientific Reports, 2020
AbstractWe aimed to compare the electrophysiology and magnetic resonance neurography (MRN) results of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) subtypes and to explore the progression from atypical CIDP to typical CIDP. We collected the medical records of 45 CIDP patients to analyse the rate of progression from atypical CIDP to ...
Feng, Yuan, Zhang, Yu, Su, Xiaoyun, Zheng, Chuansheng, Lu, Zuneng   +4 more
openaire   +2 more sources

Chronic Inflammatory Demyelinating Polyneuropathy and Evaluation of the Visual Evoked Potentials: A Review of the Literature

Medicina, 2023
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder characterised by the progressive demyelination of peripheral nerves, resulting in motor and sensory deficits.
Periklis Tsoumanis, Aikaterini Kitsouli, Christos Stefanou, Georgios Papathanakos, Stefanos Stefanou, Kostas Tepelenis, Hercules Zikidis, Afroditi Tsoumani, Paraskevas Zafeiropoulos, Panagiotis Kitsoulis, Panagiotis Kanavaros   +10 more
doaj   +1 more source

CIDP and isolated osteosclerotic myeloma [PDF]

Neurology, 2004
A 44-year-old man developed a progressive severe tetraparesis and hypesthesia within 4 months due to chronic inflammatory demyelinating polyneuropathy (CIDP); a diagnosis reached through motor nerve conduction studies, CSF analysis, and …
J, Nickel, E, Neuen-Jacob, A, Saleh, N, Gattermann, H-P, Hartung, H, Köller   +5 more
openaire   +2 more sources